Radiation Therapy Oncology Group ( RTOG ) 9508 showed a survival advantage for patients with 1 but not 2 or 3 brain metastasis ( BM ) treated with whole-brain radiation therapy ( WBRT ) and stereotactic radiosurgery ( SRS ) versus WBRT alone .